Onesource Specialty Pharma Ltd
Onesource Specialty Pharma Ltd (ONESOURCE) last traded at ₹1,517, a market capitalisation of ₹17,392 crore. Over the past 52 weeks the stock has ranged between ₹1,057 and ₹1,925. Onesource Specialty Pharma Ltd last reported results for the quarter ended Jun 2026, with sales of ₹449 crore and net profit of ₹25 crore. Figures are as of 25 Aug 2026 and are not real time.
Onesource Specialty Pharma Ltd share price and key metrics
Metrics as of 25 Aug 2026. Not real time.
Onesource Specialty Pharma Ltd quarterly results
In the quarter ended Jun 2026, sales were ₹449 cr, up 37.3% from ₹327 cr a year earlier.
| ₹ crore | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 334 | 393 | 426 | 327 | 376 | 290 | 428 | 449 |
| Expenses | 257 | 251 | 243 | 239 | 269 | 273 | 336 | 326 |
| Operating profit | 77 | 142 | 183 | 88 | 106 | 17 | 92 | 123 |
| OPM % | 23% | 36% | 43% | 27% | 28% | 6% | 21% | 27% |
| Other income | -1 | -94 | 2 | 2 | 3 | -2 | 2 | -0 |
| Interest | 45 | 46 | 33 | 27 | 34 | 38 | 23 | 31 |
| Depreciation | 68 | 69 | 68 | 68 | 70 | 70 | 72 | 72 |
| Profit before tax | -37 | -67 | 83 | -4 | 6 | -93 | -0 | 20 |
| Tax % | 12% | 4% | -19% | -96% | -83% | -5% | -1,630% | -23% |
| Net profit | -42 | -69 | 98 | -0 | 10 | -89 | 5 | 25 |
| EPS (₹) | — | -6.02 | 8.61 | -0.02 | 0.92 | -7.74 | 0.40 | 2.18 |
Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.
Onesource Specialty Pharma Ltd annual results
| ₹ crore | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|
| Sales | 21 | 132 | 39 | 172 | 1,445 | 1,422 | 1,543 |
| Operating profit | -71 | -97 | -161 | -82 | 467 | 304 | 339 |
| OPM % | -334% | -73% | -415% | -48% | 32% | 21% | 22% |
| Net profit | -121 | -231 | -800 | -391 | -18 | -74 | -49 |
| EPS (₹) | — | — | — | — | -1.57 | -6.44 | -4.24 |
TTM is the trailing twelve months to the most recent quarter.
Onesource Specialty Pharma Ltd growth and returns
- 10 Years
- %
- 5 Years
- 131%
- 3 Years
- 232%
- TTM
- 4%
- 10 Years
- %
- 5 Years
- 8%
- 3 Years
- 24%
- TTM
- -142%
- 10 Years
- %
- 5 Years
- %
- 3 Years
- %
- 1 Year
- -19%
- 10 Years
- %
- 5 Years
- -10%
- 3 Years
- -2%
- Last Year
- -1%
Onesource Specialty Pharma Ltd shareholding pattern
Promoters held 30.48% at Jun 2026, up from 29.78% at Jun 2025. FIIs 19.19% and DIIs 23.37%.
| % held | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|
| Promoters | 37.76% | 34.25% | 29.78% | 29.77% | 29.93% | 30.48% | 30.48% |
| FIIs | 17.44% | 18.54% | 18.69% | 19.39% | 19.24% | 17.50% | 19.19% |
| DIIs | 12.56% | 18.03% | 18.09% | 18.48% | 18.80% | 20.61% | 23.37% |
| Public | 32.24% | 29.17% | 33.42% | 32.34% | 32.01% | 31.40% | 26.95% |
| No. of shareholders | 98,425 | 82,712 | 87,760 | 87,416 | 84,595 | 79,460 | 77,899 |
As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.
Onesource Specialty Pharma Ltd corporate filings
- Intimation of Credit Rating issued by India Ratings and Research Private Limited vide press release dated August 17, 2026Company Updatemedium impact
Cruxal's analysis: OneSource Specialty Pharma Limited has secured a credit rating upgrade to 'IND A' with a…
Read the full analysis
This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.
Track Onesource Specialty Pharma Ltd
Cruxal reads every Onesource Specialty Pharma Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Cruxal publishes market data and coverage for information only. Nothing here is investment advice.